EURURO Vol. 71 No. 5

E161 844

Corrigendum re: ‘‘Serum Levels of MicroRNA miR-371a-3p:
A Sensitive and Specific New Biomarker for Germ Cell Tumours’’
[Eur Urol 2017;71:213–20]
Klaus-Peter Dieckmann Arlo Radtke Meike Spiekermann Thomas Balks
Cord Matthies Pascal Becker Christian Ruf Christoph Oing Karin Oechsle
Carsten Bokemeyer Johannes Hammel Sebastian Melchior Werner Wosniok
Gazanfer Belge
a Department of Urology, Albertinen Krankenhaus, Hamburg, Germany; bCentre for Human Genetics, University of Bremen, Bremen, Germany; c Department
of Urology, Bundeswehr Krankenhaus, Hamburg, Germany; dDepartment of Medical Oncology, Universita¨tsklinikum Hamburg-Eppendorf, Hamburg,
Germany; e Department of Urology, Zentralklinikum Bremen, Bremen, Germany; f Institute of Statistics, University of Bremen, Bremen, Germany
We write to clarify our conflicts of interest for this work. Klaus-Peter Dieckmann, Meike Spiekermann, and Gazanfer Belge
hold stock in miRdetect GmbH, Bremen, a biotech company aiming to develop a commercial laboratory test for measuring
microRNAs in body fluids. The miRdetect venture was formally registered as a legal entity in the Unternehmensregister
(German Business Register) on March 12, 2015 to avail of small/medium enterprise funding and to protect the name
miRdetect. Two of the authors (G. Belge and M. Spiekermann) each owned 20% of that enterprise. After submission of this
manuscript to European Urology , Meike Spiekermann was employed by miRdetect GmbH (since May 2016). miRdetect
became an active company with GmbH status with office rooms, employees, a Chief Executive Officer, and regular financial
transactions on April 11, 2016. miRdetect GmbH holds a patent for measurement of microRNAs in body fluids at the limit of
detection. The remaining authors have no conflicts of interest to disclose.
ava ilable at
journal homepage:
DOI of original article: .
* Corresponding author. Department of Urology, Albertinen Krankenhaus, Suentelstrasse 11a, D-22457 Hamburg, Germany. Tel. +40 55 882253;
Fax: +40 55 882381.
E-mail address: (K.-P. Dieckmann).
0302-2838/